 | • レポートコード：GIR-105X17118 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、予防ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。予防ワクチンの種類別市場規模（筋肉注射、点鼻薬、皮内注射）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・予防ワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Sanofi、AstraZeneca、CSL Ltd、Abbott、GlaxoSmithKline、Serum Institute of India ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：筋肉注射、点鼻薬、皮内注射 ・用途別分析2016年-2026年：病院、診療所、その他 ・予防ワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・予防ワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・予防ワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・予防ワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・予防ワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Preventive Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Preventive Vaccines size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Preventive Vaccines market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Preventive Vaccines market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Intramuscular Injection
Nasal Spray
Intradermal Shot
Market segment by Application can be divided into
Hospital
Clinic
Other
The key market players for global Preventive Vaccines market are listed below:
Sanofi
AstraZeneca
CSL Ltd
Abbott
GlaxoSmithKline
Serum Institute of India
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Preventive Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Preventive Vaccines Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Intramuscular Injection
1.2.3 Nasal Spray
1.2.4 Intradermal Shot
1.3 Market Analysis by Application
1.3.1 Overview: Global Preventive Vaccines Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Preventive Vaccines Market Size & Forecast
1.4.1 Global Preventive Vaccines Sales in Value (2016-2026))
1.4.2 Global Preventive Vaccines Sales in Volume (2016-2026)
1.4.3 Global Preventive Vaccines Price by Type (2016-2026) & (USD/Doses)
1.5 Global Preventive Vaccines Production Capacity Analysis
1.5.1 Global Preventive Vaccines Total Production Capacity (2016-2026)
1.5.2 Global Preventive Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Preventive Vaccines Market Drivers
1.6.2 Preventive Vaccines Market Restraints
1.6.3 Preventive Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Preventive Vaccines Product and Services
2.1.4 Sanofi Preventive Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Preventive Vaccines Product and Services
2.2.4 AstraZeneca Preventive Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 CSL Ltd
2.3.1 CSL Ltd Details
2.3.2 CSL Ltd Major Business
2.3.3 CSL Ltd Preventive Vaccines Product and Services
2.3.4 CSL Ltd Preventive Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business
2.4.3 Abbott Preventive Vaccines Product and Services
2.4.4 Abbott Preventive Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Preventive Vaccines Product and Services
2.5.4 GlaxoSmithKline Preventive Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Serum Institute of India
2.6.1 Serum Institute of India Details
2.6.2 Serum Institute of India Major Business
2.6.3 Serum Institute of India Preventive Vaccines Product and Services
2.6.4 Serum Institute of India Preventive Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Preventive Vaccines Sales by Manufacturer
3.1 Global Preventive Vaccines Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Preventive Vaccines Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Preventive Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Preventive Vaccines Manufacturer Market Share
3.4.2 Top 6 Preventive Vaccines Manufacturer Market Share
3.5 Global Preventive Vaccines Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Preventive Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Preventive Vaccines Market Size by Region
4.1.1 Global Preventive Vaccines Sales in Volume by Region (2016-2026)
4.1.2 Global Preventive Vaccines Revenue by Region (2016-2026)
4.2 North America Preventive Vaccines Revenue (2016-2026)
4.3 Europe Preventive Vaccines Revenue (2016-2026)
4.4 Asia-Pacific Preventive Vaccines Revenue (2016-2026)
4.5 South America Preventive Vaccines Revenue (2016-2026)
4.6 Middle East and Africa Preventive Vaccines Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Preventive Vaccines Sales in Volume by Type (2016-2026)
5.2 Global Preventive Vaccines Revenue by Type (2016-2026)
5.3 Global Preventive Vaccines Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Preventive Vaccines Sales in Volume by Application (2016-2026)
6.2 Global Preventive Vaccines Revenue by Application (2016-2026)
6.3 Global Preventive Vaccines Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Preventive Vaccines Sales by Type (2016-2026)
7.2 North America Preventive Vaccines Sales by Application (2016-2026)
7.3 North America Preventive Vaccines Market Size by Country
7.3.1 North America Preventive Vaccines Sales in Volume by Country (2016-2026)
7.3.2 North America Preventive Vaccines Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Preventive Vaccines Sales by Type (2016-2026)
8.2 Europe Preventive Vaccines Sales by Application (2016-2026)
8.3 Europe Preventive Vaccines Market Size by Country
8.3.1 Europe Preventive Vaccines Sales in Volume by Country (2016-2026)
8.3.2 Europe Preventive Vaccines Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Preventive Vaccines Sales by Type (2016-2026)
9.2 Asia-Pacific Preventive Vaccines Sales by Application (2016-2026)
9.3 Asia-Pacific Preventive Vaccines Market Size by Region
9.3.1 Asia-Pacific Preventive Vaccines Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Preventive Vaccines Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Preventive Vaccines Sales by Type (2016-2026)
10.2 South America Preventive Vaccines Sales by Application (2016-2026)
10.3 South America Preventive Vaccines Market Size by Country
10.3.1 South America Preventive Vaccines Sales in Volume by Country (2016-2026)
10.3.2 South America Preventive Vaccines Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Preventive Vaccines Sales by Type (2016-2026)
11.2 Middle East & Africa Preventive Vaccines Sales by Application (2016-2026)
11.3 Middle East & Africa Preventive Vaccines Market Size by Country
11.3.1 Middle East & Africa Preventive Vaccines Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Preventive Vaccines Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Preventive Vaccines Typical Distributors
12.3 Preventive Vaccines Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Preventive Vaccines Revenue by Type, (USD Million), 2021-2026
Table 2. Global Preventive Vaccines Revenue by Application, (USD Million), 2021-2026
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Preventive Vaccines Product and Services
Table 6. Sanofi Preventive Vaccines Sales (K Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca Major Business
Table 9. AstraZeneca Preventive Vaccines Product and Services
Table 10. AstraZeneca Preventive Vaccines Sales (K Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. CSL Ltd Basic Information, Manufacturing Base and Competitors
Table 12. CSL Ltd Major Business
Table 13. CSL Ltd Preventive Vaccines Product and Services
Table 14. CSL Ltd Preventive Vaccines Sales (K Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Abbott Basic Information, Manufacturing Base and Competitors
Table 16. Abbott Major Business
Table 17. Abbott Preventive Vaccines Product and Services
Table 18. Abbott Preventive Vaccines Sales (K Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 20. GlaxoSmithKline Major Business
Table 21. GlaxoSmithKline Preventive Vaccines Product and Services
Table 22. GlaxoSmithKline Preventive Vaccines Sales (K Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 24. Serum Institute of India Major Business
Table 25. Serum Institute of India Preventive Vaccines Product and Services
Table 26. Serum Institute of India Preventive Vaccines Sales (K Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Global Preventive Vaccines Sales by Manufacturer (2019-2021e) & (K Doses)
Table 28. Global Preventive Vaccines Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 29. Market Position of Manufacturers in Preventive Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 30. Global Preventive Vaccines Production Capacity by Company, (K Doses): 2020 VS 2021
Table 31. Head Office and Preventive Vaccines Production Site of Key Manufacturer
Table 32. Global Preventive Vaccines Sales by Region (2016-2021e) & (K Doses)
Table 33. Global Preventive Vaccines Sales by Region (2021-2026) & (K Doses)
Table 34. Global Preventive Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 35. Global Preventive Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 36. Global Preventive Vaccines Sales by Type (2016-2021e) & (K Doses)
Table 37. Global Preventive Vaccines Sales by Type (2021-2026) & (K Doses)
Table 38. Global Preventive Vaccines Revenue by Type (2016-2021e) & (USD Million)
Table 39. Global Preventive Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 40. Global Preventive Vaccines Price by Type (2016-2021e) & (USD/Doses)
Table 41. Global Preventive Vaccines Price by Type (2021-2026) & (USD/Doses)
Table 42. Global Preventive Vaccines Sales by Application (2016-2021e) & (K Doses)
Table 43. Global Preventive Vaccines Sales by Application (2021-2026) & (K Doses)
Table 44. Global Preventive Vaccines Revenue by Application (2016-2021e) & (USD Million)
Table 45. Global Preventive Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 46. Global Preventive Vaccines Price by Application (2016-2021e) & (USD/Doses)
Table 47. Global Preventive Vaccines Price by Application (2021-2026) & (USD/Doses)
Table 48. North America Preventive Vaccines Sales by Country (2016-2021e) & (K Doses)
Table 49. North America Preventive Vaccines Sales by Country (2021-2026) & (K Doses)
Table 50. North America Preventive Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 51. North America Preventive Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 52. North America Preventive Vaccines Sales by Type (2016-2021e) & (K Doses)
Table 53. North America Preventive Vaccines Sales by Type (2021-2026) & (K Doses)
Table 54. North America Preventive Vaccines Sales by Application (2016-2021e) & (K Doses)
Table 55. North America Preventive Vaccines Sales by Application (2021-2026) & (K Doses)
Table 56. Europe Preventive Vaccines Sales by Country (2016-2021e) & (K Doses)
Table 57. Europe Preventive Vaccines Sales by Country (2021-2026) & (K Doses)
Table 58. Europe Preventive Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 59. Europe Preventive Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 60. Europe Preventive Vaccines Sales by Type (2016-2021e) & (K Doses)
Table 61. Europe Preventive Vaccines Sales by Type (2021-2026) & (K Doses)
Table 62. Europe Preventive Vaccines Sales by Application (2016-2021e) & (K Doses)
Table 63. Europe Preventive Vaccines Sales by Application (2021-2026) & (K Doses)
Table 64. Asia-Pacific Preventive Vaccines Sales by Region (2016-2021e) & (K Doses)
Table 65. Asia-Pacific Preventive Vaccines Sales by Region (2021-2026) & (K Doses)
Table 66. Asia-Pacific Preventive Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 67. Asia-Pacific Preventive Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 68. Asia-Pacific Preventive Vaccines Sales by Type (2016-2021e) & (K Doses)
Table 69. Asia-Pacific Preventive Vaccines Sales by Type (2021-2026) & (K Doses)
Table 70. Asia-Pacific Preventive Vaccines Sales by Application (2016-2021e) & (K Doses)
Table 71. Asia-Pacific Preventive Vaccines Sales by Application (2021-2026) & (K Doses)
Table 72. South America Preventive Vaccines Sales by Country (2016-2021e) & (K Doses)
Table 73. South America Preventive Vaccines Sales by Country (2021-2026) & (K Doses)
Table 74. South America Preventive Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 75. South America Preventive Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 76. South America Preventive Vaccines Sales by Type (2016-2021e) & (K Doses)
Table 77. South America Preventive Vaccines Sales by Type (2021-2026) & (K Doses)
Table 78. South America Preventive Vaccines Sales by Application (2016-2021e) & (K Doses)
Table 79. South America Preventive Vaccines Sales by Application (2021-2026) & (K Doses)
Table 80. Middle East & Africa Preventive Vaccines Sales by Country (2016-2021e) & (K Doses)
Table 81. Middle East & Africa Preventive Vaccines Sales by Country (2021-2026) & (K Doses)
Table 82. Middle East & Africa Preventive Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 83. Middle East & Africa Preventive Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 84. Middle East & Africa Preventive Vaccines Sales by Type (2016-2021e) & (K Doses)
Table 85. Middle East & Africa Preventive Vaccines Sales by Type (2021-2026) & (K Doses)
Table 86. Middle East & Africa Preventive Vaccines Sales by Application (2016-2021e) & (K Doses)
Table 87. Middle East & Africa Preventive Vaccines Sales by Application (2021-2026) & (K Doses)
Table 88. Direct Channel Pros & Cons
Table 89. Indirect Channel Pros & Cons
Table 90. Preventive Vaccines Typical Distributors
Table 91. Preventive Vaccines Typical Customers
List of Figures
Figure 1. Preventive Vaccines Picture
Figure 2. Global Preventive Vaccines Sales Market Share by Type in 2020
Figure 3. Intramuscular Injection
Figure 4. Nasal Spray
Figure 5. Intradermal Shot
Figure 6. Global Preventive Vaccines Sales Market Share by Application in 2020
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Other
Figure 10. Global Preventive Vaccines Market Size, (USD Million) & (K Doses): 2020 VS 2021 VS 2026
Figure 11. Global Preventive Vaccines Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Preventive Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Preventive Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Preventive Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Preventive Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Preventive Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Preventive Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Preventive Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Preventive Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Preventive Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Preventive Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Preventive Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Preventive Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Preventive Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Preventive Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Preventive Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Preventive Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Preventive Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Preventive Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Preventive Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Preventive Vaccines Sales (2016-2026) & (K Doses)
Figure 32. Global Preventive Vaccines Production Capacity (2016-2026) & (K Doses)
Figure 33. Global Preventive Vaccines Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Preventive Vaccines Market Drivers
Figure 35. Preventive Vaccines Market Restraints
Figure 36. Preventive Vaccines Market Trends
Figure 37. Global Preventive Vaccines Sales Market Share by Manufacturer in 2020
Figure 38. Global Preventive Vaccines Revenue Market Share by Manufacturer in 2020
Figure 39. Preventive Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Preventive Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Preventive Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Preventive Vaccines Sales Market Share by Region (2016-2026)
Figure 43. Global Preventive Vaccines Revenue Market Share by Region (2016-2026)
Figure 44. North America Preventive Vaccines Revenue (2016-2026) & (USD Million)
Figure 45. Europe Preventive Vaccines Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Preventive Vaccines Revenue (2016-2026) & (USD Million)
Figure 47. South America Preventive Vaccines Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Preventive Vaccines Revenue (2016-2026) & (USD Million)
Figure 49. Global Preventive Vaccines Sales Market Share by Type (2016-2026)
Figure 50. Global Preventive Vaccines Revenue Market Share by Type (2016-2026)
Figure 51. Global Preventive Vaccines Price by Type (2016-2026) & (USD/Doses)
Figure 52. Global Preventive Vaccines Sales Market Share by Application (2016-2026)
Figure 53. Global Preventive Vaccines Revenue Market Share by Application (2016-2026)
Figure 54. Global Preventive Vaccines Price by Application (2016-2026) & (USD/Doses)
Figure 55. North America Preventive Vaccines Sales Market Share by Country (2016-2026)
Figure 56. North America Preventive Vaccines Revenue Market Share by Country (2016-2026)
Figure 57. North America Preventive Vaccines Sales Market Share by Type (2016-2026)
Figure 58. North America Preventive Vaccines Sales Market Share by Application (2016-2026)
Figure 59. Europe Preventive Vaccines Sales Market Share by Country (2016-2026)
Figure 60. Europe Preventive Vaccines Revenue Market Share by Country (2016-2026)
Figure 61. Europe Preventive Vaccines Sales Market Share by Type (2016-2026)
Figure 62. Europe Preventive Vaccines Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Preventive Vaccines Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Preventive Vaccines Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Preventive Vaccines Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Preventive Vaccines Sales Market Share by Application (2016-2026)
Figure 67. South America Preventive Vaccines Sales Market Share by Country (2016-2026)
Figure 68. South America Preventive Vaccines Revenue Market Share by Country (2016-2026)
Figure 69. South America Preventive Vaccines Sales Market Share by Type (2016-2026)
Figure 70. South America Preventive Vaccines Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Preventive Vaccines Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Preventive Vaccines Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Preventive Vaccines Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Preventive Vaccines Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
感染性ワクチンの世界市場予測 2023年：メーカー別、地域別、種類・用途別 A vaccine is a medical product primarily designed to stimulate antibodies against an infectious disease which help to improve the immunity of the target body. Scope of the Report: This report focuses on the Infectious Vaccines in global market, especially in North America, Europe and Asia-Pacific, S…- 世界の点鼻スプレー式インフルエンザワクチン市場 2021：企業別、地域別、種類・用途別 The Nasal Spray Flu Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 世界のジフテリアワクチン市場 2021：企業別、地域別、種類・用途別 The Diphtheria Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- 世界の黄熱病ワクチン市場 2021：企業別、地域別、種類・用途別 The Yellow Fever Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
- 世界のオーエスキー病ワクチン市場 2021：企業別、地域別、種類・用途別 The Aujeszky Disease Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…